Sir Murray Frederick Brennan GNZM (born 2 April 1940) is a New Zealand surgeon, oncologist, cancer researcher, and academic. From 1985 to 2006, he was chairman of the surgery department of the Memorial Sloan Kettering Cancer Center in New York City, United States.
Born in the Auckland suburb of Onehunga in 1940, and educated first at Onehunga Primary School. [1] [2] Brennan attended the University of Otago, gaining a BSc in 1962, and MB ChB in 1964. [3] A rugby union player, he played 12 matches for Otago between 1964 and 1965. [4] He also served as president of the Otago University Students' Association. [4]
In 1967 he was appointed as an assistant lecturer in physiology and surgery at Otago, [3] and in 1970 he moved to the United States and undertook laboratory and clinical work at Peter Bent Brigham Hospital, Harvard Medical School and the Joslin Research Laboratories. After a period as head of the surgical metabolism section at the National Cancer Institute, he became chief of the gastric and mixed tumor service at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York City in 1981. Between 1985 and 2006 he was chairman of the surgery department at MSKCC. [5]
Brennan has authored over 1,000 publications and has served on the editorial board the Australian and New Zealand Journal of Surgery since 1985. [4] [6]
He co-founded Dugri in 2020, where he has worked with Jonathan Lewis, Yotam Dagan and others to help hone the development of next-generation technology platforms for scale in the management of operational stress management and PTSD. [7]
Brennan was awarded an honorary Doctor of Science (DSc) degree by the University of Otago in 1997. [8] In the 2015 New Year Honours, he was awarded one of New Zealand's highest honours when he was appointed Knight Grand Companion of the New Zealand Order of Merit for services to medicine. [6] [9]
Memorial Sloan Kettering Cancer Center is a cancer treatment and research institution in Manhattan in New York City. It was founded in 1884 as the New York Cancer Hospital. MSKCC is one of 72 National Cancer Institute-designated Comprehensive Cancer Centers. It had already been renamed and relocated, to its present site, when the Sloan-Kettering Institute for Cancer Research was founded in 1945, and built adjacent to the hospital. The two medical entities formally coordinated their operations in 1960, and formally merged as a single entity in 1980. Its main campus is located at 1275 York Avenue between 67th and 68th Streets in Manhattan.
The Tri-Institutional MD–PhD Program is an academic program of study based in New York City that was formed by combining earlier MD–PhD programs that had their inceptions in 1972. The current version of the program, which is operated by Weill Cornell Medicine, Rockefeller University, and Memorial Sloan Kettering Cancer Center's Sloan Kettering Institute, was created in 1991.
Monica Morrow is a breast cancer surgeon and Chief of Breast Surgery at Memorial Sloan-Kettering Cancer Center in Manhattan, NY. Her first day seeing patients in clinic as Chief at MSKCC was Tuesday, February 19, 2008. She formerly served as the chairman of surgical oncology at the Fox Chase Cancer Center. She is the President-elect of the Society for Surgical Oncology.
Josep Baselga i Torres, known in Spanish as José Baselga, was a Spanish medical oncologist and researcher focused on the development of novel molecular targeted agents, with a special emphasis in breast cancer. Through his career he was associated with the Memorial Sloan Kettering Cancer Center, Vall d'Hebron Institute of Oncology, and the Massachusetts General Hospital in their hematology and oncology divisions. He led the development of the breast cancer treatment Herceptin, a monoclonal antibody, that targets the HER2 protein, which is impacted in aggressive breast cancers.
William S. Breitbart, FAPM, is an American psychiatrist in Psychosomatic Medicine, Psycho-oncology, and Palliative Care. He is the Jimmie C Holland Chair in Psychiatric Oncology, and the Chief of the Psychiatry Service, Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, He is a Professor of Clinical Psychiatry at Weill Medical College of Cornell University. He was president of the Academy of Psychosomatic Medicine, and the Editor-in-Chief of Palliative and Supportive Care.
The Band of Parents is a 501(c)(3) nonprofit organization. Formed in July 2007 and incorporated in October 2007, it was founded by approximately 100 parents of young children with neuroblastoma who were treated at Memorial Sloan Kettering Cancer Center (MSKCC). Its purpose is to fund the development of new therapies for neuroblastoma that would not otherwise be pursued by research institutions or the pharmaceutical industry. The organization has become the largest single funder of neuroblastoma research at MSKCC.
Jonathan J. Lewis is an American surgeon, biomedical researcher and entrepreneur. He was trained in surgery in South Africa, Britain, and the United States, and is a fellow of both the Royal College of Surgeons and the American College of Surgeons. Dr. Lewis was awarded an MB.B.Ch. from University of the Witwatersrand School of Medicine, and his Ph.D. in Molecular Biology from Witwatersrand and Yale School of Medicine. He completed his Surgical Residency at Charlotte Maxeke Johannesburg Academic Hospital and at Yale-New Haven Hospital. Lewis was a Professor of Surgery and Medicine Memorial Sloan-Kettering Cancer Center, before working in the biotechnology and healthcare industries, serving in several CEO and Chairman roles. He is currently chairman and co-founder of the Molecular Ninja Group and chairman and co-founder of Dugri Inc.
Joan Massagué, is a Spanish biologist and the current director of the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center. He is also an internationally recognized leader in the study of both cancer metastasis and growth factors that regulate cell behavior, as well as a professor at the Weill Cornell Graduate School of Medical Sciences.
Robert E. Wittes was Physician-in-Chief of Memorial Sloan-Kettering Cancer Center, from 2002 until December 31, 2012. Prior to his appointment at MSKCC, he was Deputy Director for Extramural Sciences and Director of the Division of Cancer Treatment and Diagnosis at the National Cancer Institute, where he oversaw NCI's extramural clinical and basic research programs, including the evaluation of new therapeutics, diagnostics, and translational research. Wittes is a fellow of the American College of Physicians, a member of the American Association for Cancer Research, the American Society of Clinical Oncology, and the American Federation for Medical Research. In addition to his institutional affiliations, Dr. Wittes has served as editor-in-chief of the Journal of the National Cancer Institute and Oncology. He has served on the editorial boards of Clinical Cancer Research, Current Opinion in Oncology, The American Journal of Clinical Oncology; Cancer Investigation, and The International Journal of Radiation Oncology-Biology & Physics, among others.
George Bosl is an American cancer researcher, holder of the Patrick M. Byrne Chair in Clinical Oncology at the Memorial Sloan-Kettering Cancer Center in New York City, and is a professor of medicine at the Weill Cornell Medical College. In 1997, he was appointed chair of the Department of Medicine at Sloan-Kettering, a position which he held until 2015. In 2019, he was named Memorial Sloan Kettering's first ombudsperson.
Peter T. Scardino is an American cancer surgeon, researcher, and author expert in genitourinary and urological cancers particularly cancer of the prostate. He is chair of the Department of Surgery at Memorial Sloan Kettering Cancer Center.
John H. Healey is an American cancer surgeon, researcher, and expert in the surgical treatment of benign and malignant bone tumors and other musculoskeletal cancers. He serves as Chair of the Orthopaedic Service and Stephen P. McDermott Chair in Surgery at Memorial Sloan-Kettering Cancer Center (MSKCC), as well as Professor of Surgery at Weill Cornell Medical College, in New York, NY.
Kenneth Offit is an American cancer geneticist and oncologist known for his discoveries with respect to the genetic bases of breast, colorectal, and lymphoid cancers. He is currently Chief of the Clinical Genetics Service and the Robert and Kate Niehaus Chair in Inherited Cancer Genomics at Memorial Sloan Kettering Cancer Center. Offit is also a member of the Program in Cancer Biology and Genetics at the Sloan-Kettering Institute and Professor of Medicine and Healthcare Policy and Research at Weill Cornell Medical College. He was previously a member of both the Board of Scientific Counselors of the National Cancer Institute and the Evaluation of Genomic Applications in Practice and Prevention working group of the U.S. Centers for Disease Control.
Nikola Panayot Pavletich is the former chair of structural biology at Memorial Sloan Kettering Cancer Center.
Jeffrey Drebin is a surgeon and scientist. He serves as the Department of Surgery Chair at Memorial Sloan Kettering.
Robert Maki is an American medical oncologist, Professor of Medicine at the Hospital of the University of Pennsylvania, He is a specialist in the management of and translational research regarding sarcoma, the group of connective tissue malignancies that include leiomyosarcoma, gastrointestinal stromal tumor (GIST), liposarcoma, angiosarcoma, Ewing sarcoma, desmoid tumor and many others.
Viviane Tabar is an American neurosurgeon, the Chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center in New York since 2017.
Lisa Marie DeAngelis is an American neuro-oncologist and Physician-in-Chief and Chief Medical Officer at Memorial Sloan Kettering Cancer Center.
Carol L. Brown is the Nicholls-Biondi Chair for Health Equity at Memorial Sloan Kettering Cancer Center and a professor at Weill Cornell Medical College. She is a surgeon known for her work on gynecological cancers.
Bayard Delafield Clarkson Sr. is an American physician, hematologist, and oncologist.